CUAMC
AERI

China Universal Asset Management Company’s Aerie Pharmaceuticals AERI Stock Holding History

China Universal Asset Management Company’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-463
Closed -$7K – 510
2022
Q3 		$7K Buy
+463
New +$5.38K ﹤0.01% 243

China Universal Asset Management Company's AERI Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 463 shares — an estimated $7K sold.

China Universal Asset Management Company first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $7K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 463 Aerie Pharmaceuticals shares in Q4 2022, an estimated $7K.
  • China Universal Asset Management Company first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Aerie Pharmaceuticals position peaked at $7K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.